Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA - Wikidata - wikimedia - TriplyDB

Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA

Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA

http://www.wikidata.org/entity/Q28081274

about

Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses New horizon for radical cure of chronic hepatitis B virus infection.Drugs in Development for Hepatitis B.Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA.

P2860

Q27468956-C371A6CD-B0A4-425A-BBC9-792E061CC0A0 Q40593364-F4C04C32-EB67-4969-887E-FD851A84C1BA Q52764230-300BA6F3-B04C-47D5-A410-1FE3B17F22E0 Q55380360-7549B401-E865-488F-B21D-9A827B5187D3

P2860

Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA

http://www.wikidata.org/entity/Q28081274

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA

@ast

Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA

@en

Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA

@nl

type

label

Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA

@ast

Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA

@en

Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA

@nl

prefLabel

Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA

@ast

Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA

@en

Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA

@nl

P1433

Q28081274-1A3359C9-2AD4-48B1-91D2-8FB8412F2200

P1476

Q28081274-16040916-9433-4AAF-B95F-F4381CDA0AA3

P2093

Q28081274-092B291C-0633-4AE9-B584-EEAD9310BB9B

Q28081274-1C1BC016-8A9C-4ADB-9B0F-6BEC143B3678

Q28081274-4F22F016-DA80-45EC-8789-5CAB01838999

Q28081274-6DF7617D-E2E6-492D-B582-C8D74066320E

Q28081274-D1A004F2-9F31-4762-B661-BF1ECC1B1893

P2860

Q28081274-07E94A99-B16A-4A40-9614-0A0C18120E41

Q28081274-177E3563-2DDB-48CE-ABF4-B7BEC011F0F2

Q28081274-1CE52B8A-EAE2-48FF-9C39-177AB5B23498

Q28081274-265DD9A3-B74F-4BB6-B7B0-AC0D41FB7B2A

Q28081274-38D5EB2D-AF98-41C6-998F-912D1554C13A

Q28081274-56E48DC4-3C55-432C-B9FB-A3E883E6DD70

Q28081274-59293FBC-9E74-4E10-9FC8-BDC823A86E0E

Q28081274-5AC3E4DB-13D0-44BA-9852-420B021FFCF0

Q28081274-6D4939EB-6A6C-46DC-B3C8-4D96D5DFC220

Q28081274-773E1E44-30FB-4B2D-AC76-E29862F07F84

P304

Q28081274-1252242B-F705-46C2-B409-61C26D0ECFAD

P31

Q28081274-0869F20C-CA60-4F7C-A3B1-6521750E37FA

Q28081274-436bd95f-ee3c-49c0-a5e2-6727dbc78b1c

P356

Q28081274-98DAE948-FFF2-4482-A1C2-0F7DF60F209C

P407

Q28081274-E9D8D0FE-3E0B-4432-92F8-314BADBEC630

P433

Q28081274-FE192673-DF5C-4915-8159-FA4F037B88A0

P478

Q28081274-A19C87FB-6236-47F5-A738-091818E269C9

P50

Q28081274-85AF9D22-7C2B-48D0-94E1-7B7442F61796

P577

Q28081274-4A463D30-B0E9-4518-A45E-59ABA7A5D061

P698

Q28081274-E447D2DE-42FC-4572-9E42-E9FCFB07E631

P932

Q28081274-0FB5281B-B9B1-4796-B5CD-4DBF01FEF337

P356

WJG.V21.I23.7084

P1433

World Journal of Gastroenterology

P1476

Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA

@en

P2093

Akemi Takata

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Koike

http://www.w3.org/2001/XMLSchema#string

Motoko Ohno

http://www.w3.org/2001/XMLSchema#string

Takahiro Kishikawa

http://www.w3.org/2001/XMLSchema#string

Takeshi Yoshikawa

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Targeted DNA mutagenesis for the cure of chronic viral infections

Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification

Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach

Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

CRISPR-Cas systems for editing, regulating and targeting genomes

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

Novel natural mutations in the hepatitis B virus reverse transcriptase domain associated with hepatocellular carcinoma.

Hepatitis B virus biology.

P304

7084-7088

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V21.I23.7084

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Motoyuki Otsuka

P577

2015-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26109795

http://www.w3.org/2001/XMLSchema#string

P932

4476870

http://www.w3.org/2001/XMLSchema#string